TDOC Teladoc Health Inc

Price (delayed)

$151.73

Market cap

$23.45B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.27

Enterprise value

$24.14B

Highlights
Teladoc Health's gross profit has soared by 129% YoY and by 28% from the previous quarter
TDOC's revenue has soared by 126% year-on-year and by 25% since the previous quarter
TDOC's debt has soared by 197% YoY but it is down by 4.8% from the previous quarter
TDOC's quick ratio is down by 42% year-on-year but it is up by 21% since the previous quarter
TDOC's net income is down by 35% since the previous quarter
The company's EPS fell by 17% QoQ

Key stats

What are the main financial stats of TDOC
Market
Shares outstanding
154.53M
Market cap
$23.45B
Enterprise value
$24.14B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.46
Price to sales (P/S)
16.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
17.66
Earnings
Revenue
$1.37B
EBIT
-$584.97M
EBITDA
-$465.68M
Free cash flow
-$103.56M
Per share
EPS
-$6.27
Free cash flow per share
-$0.68
Book value per share
$103.66
Revenue per share
$8.98
TBVPS
$7.45
Balance sheet
Total assets
$17.58B
Total liabilities
$1.75B
Debt
$1.42B
Equity
$15.83B
Working capital
$771.97M
Liquidity
Debt to equity
0.09
Current ratio
3.96
Quick ratio
3.46
Net debt/EBITDA
-1.5
Margins
EBITDA margin
-34.1%
Gross margin
66%
Net margin
-47.9%
Operating margin
-41.7%
Efficiency
Return on assets
-6.4%
Return on equity
-7.4%
Return on invested capital
-45.5%
Return on capital employed
-3.4%
Return on sales
-42.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TDOC stock price

How has the Teladoc Health stock price performed over time
Intraday
-0.46%
1 week
0.86%
1 month
8.63%
1 year
-19.47%
YTD
-24.12%
QTD
-16.52%

Financial performance

How have Teladoc Health's revenue and profit performed over time
Revenue
$1.37B
Gross profit
$902.43M
Operating income
-$570.09M
Net income
-$655.18M
Gross margin
66%
Net margin
-47.9%
TDOC's net margin has plunged by 196% YoY and by 8% from the previous quarter
Teladoc Health's gross profit has soared by 129% YoY and by 28% from the previous quarter
TDOC's revenue has soared by 126% year-on-year and by 25% since the previous quarter
TDOC's net income is down by 35% since the previous quarter

Growth

What is Teladoc Health's growth rate over time

Valuation

What is Teladoc Health stock price valuation
P/E
N/A
P/B
1.46
P/S
16.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
17.66
The company's EPS fell by 17% QoQ
The stock's price to book (P/B) is 74% less than its last 4 quarters average of 5.6 and 71% less than its 5-year quarterly average of 5.0
TDOC's revenue has soared by 126% year-on-year and by 25% since the previous quarter
The P/S is 42% above the 5-year quarterly average of 11.9 but 14% below the last 4 quarters average of 19.6

Efficiency

How efficient is Teladoc Health business performance
Teladoc Health's return on invested capital has shrunk by 194% YoY but it has increased by 10% QoQ
Teladoc Health's ROE has increased by 24% YoY and by 22% from the previous quarter
TDOC's return on assets is up by 17% since the previous quarter but it is down by 3.2% year-on-year
The company's return on sales rose by 9% QoQ

Dividends

What is TDOC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TDOC.

Financial health

How did Teladoc Health financials performed over time
The total liabilities has soared by 191% YoY but it has contracted by 6% from the previous quarter
TDOC's quick ratio is down by 42% year-on-year but it is up by 21% since the previous quarter
TDOC's debt is 91% less than its equity
TDOC's debt has soared by 197% YoY but it is down by 4.8% from the previous quarter
The debt to equity has plunged by 81% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.